Bristol-Myers Squibb
BMY
$65.16
Share price
-0.49%
Change (1 day)
-14.92%
Change (1 year)
Categories
Bristol-Myers Squibb (BMY) Fails to deliver data
Key failure to deliver metrics for Bristol-Myers Squibb:
- Last SEC data release: 2023-05-12
- Last 15 days FTD volume: $1.28 M
- Last 3 months FTD volume: $14.85 M
- Last year FTD volume: $0.13 B
Failures to deliver for Bristol-Myers Squibb (BMY) - 3 month history
Number of shares, 3 month chartBiweekly Failures to deliver volume for Bristol-Myers Squibb (BMY) - since 2013
Volume in USD (price x number of shares), data since 2013Bristol-Myers Squibb (BMY) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2023 | $65.98 M | -70.2% |
| 2022 | $0.22 B | 107.77% |
| 2021 | $0.10 B | -72.46% |
| 2020 | $0.38 B | -11.25% |
| 2019 | $0.43 B | 203.91% |
| 2018 | $0.14 B | -20.27% |
| 2017 | $0.17 B | 4.53% |
| 2016 | $0.17 B | -7.42% |
| 2015 | $0.18 B | 76.57% |
| 2014 | $0.10 B | 237.33% |
| 2013 | $31.21 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $48.88 M | $0.24 B | 🇺🇸 USA |
 Novartis NVS | $29.28 M | $71.27 M | 🇨🇭 Switzerland |
 Pfizer PFE | $33.95 M | $0.52 B | 🇺🇸 USA |
 AbbVie ABBV | $0.15 B | $0.46 B | 🇺🇸 USA |
 Eli Lilly LLY | $35.38 M | $0.21 B | 🇺🇸 USA |
 Amgen AMGN | $58.71 M | $0.42 B | 🇺🇸 USA |
 Sanofi SNY | $7.71 M | $0.11 B | 🇫🇷 France |
 Biogen BIIB | $6.88 M | $54.41 M | 🇺🇸 USA |
 Merck MRK | $88.22 M | $0.56 B | 🇺🇸 USA |
 AstraZeneca AZN | $37.61 M | $0.19 B | 🇬🇧 UK |